Cantor Fitzgerald Maintains Overweight on Elevance Health, Lowers Price Target to $485

Benzinga · 10/18 12:05
Cantor Fitzgerald analyst Sarah James maintains Elevance Health (NYSE:ELV) with a Overweight and lowers the price target from $600 to $485.